Inventiva (FRA:6IV) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 17, 2025)

View and export this data going back to 2020. Start your Free Trial

What is Inventiva Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Inventiva's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Inventiva's Future 3-5Y EPS without NRI Growth Rate

For the Biotechnology subindustry, Inventiva's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Inventiva's Future 3-5Y EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Inventiva's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Inventiva's Future 3-5Y EPS without NRI Growth Rate falls into.

Save Embed

;

Save Embed

;

Inventiva (FRA:6IV) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Inventiva Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Inventiva's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Inventiva Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Inventiva SA (FRA:6IV) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

IVA:USA 0RNK:UK IVA:France

Address

50 rue de Dijon, Daix, FRA, 21121

Website

https://www.inventivapharma.com

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Inventiva Headlines

No Headlines